Bluejay Diagnostics, Inc.

Contributing Author

Recent Articles by Bluejay Diagnostics, Inc.

Apr-07	Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial BJDX GlobeNewswire
Mar-12	Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting BJDX GlobeNewswire
Mar-06	Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook BJDX GlobeNewswire
Feb-20	Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised BJDX GlobeNewswire
Feb-17	Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON II Study and Advances Manufacturing Readiness into 2026 BJDX GlobeNewswire
Jan-27	Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split BJDX GlobeNewswire
Dec-29	Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production BJDX GlobeNewswire
Nov-10	Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships BJDX GlobeNewswire
Oct-10	Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules BJDX -10.66% BJDX GlobeNewswire
Oct-09	Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules BJDX +75.40% GlobeNewswire
Oct-09	Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform BJDX +75.40% GlobeNewswire
Aug-07	Bluejay Diagnostics Provides Second Quarter Business and Corporate Update BJDX GlobeNewswire
Jun-03	Bluejay Diagnostics Provides Mid-Year Business and Corporate Update BJDX GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)